News & AnalysisPreciseDx collects $10.75mPreciseDx, a cancer risk stratification company. has raised $10.75 million in funding.ByIris Dorbian18 January 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs